Amgen | Capital Social Ordinario



Ordinary Share Capital Cambio Fecha
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
ALKERMES USD 1.8M 35K 2025-03
Amgen USD 33.58B 45M 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 282K 4K 2025-01
Genmab DKK 66M 0 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Takeda JPY 1.69T 0 2024-12
Teva Pharmaceutical Industries USD 58M 0 2024-09
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Amgen Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.